Congress Scrutinizes FDA’s Role in CBD Regulation

Congress Scrutinizes FDA’s Role in CBD Regulation

Jonathan Miller, general counsel at the U.S. Hemp Roundtable represented hemp stakeholders at a congressional hearing last week to determine if the U.S. Food and Drug Administration (FDA) had failed to meet its charter obligations by not moving to regulate CBD.

The FDA has

Membership required to view content.
that it does not have the authority to regulate CBD, nor is there an existing regulatory framework for cannabinoids, they argue.  FDA is reluctant to wade into cannabis.  It is a complicated subject, with overlapping agency interests, and many decades of entrenched policy that makes the issue radioactive for…

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

05.20.2024

Strong feed demand boosts choice white grease market

Strong feed demand boosts choice white grease market

Choice white grease (CWG) prices rose on Monday May 20, supported by the market expectation of tighter supply heading into the long holiday weekend in the US and on...

05.20.2024

Lower cattle herd expectations signal tightening cattle products

Lower cattle herd expectations signal tightening cattle products

US animal proteins were steady on Monday May 20, with limited trade reported and most testing the pre-holiday market.

US cattle slaughter and CME cattle futures
Fastmarkets’ research...

05.20.2024

Central Illinois soybean crush margins rebound from previous low

Central Illinois soybean crush margins rebound from previous low

Chicago Mercantile Exchange (CME) grain prices shifted higher across the board on Monday May 20.

The July soybean futures contract increased by 20 cents per bushel to settle...

Latest Tweets